Join the Texas Pain Society and Pain Physician Kenneth Finn, MD to hear about the science of medical marijuana. 

Hear from Dr. Finn on what the latest medical studies tell us about cannabis in healthcare. Learn about the intended (and unintended) consequences of medical marijuana in treating any patient. What have we learned from this emerging industry in other states? Texans need to know. 

April 13, 2023 from 6:00-7:00 p.m. CST

 


Kenn Finn, MD President of American Board of Pain Medicine and Vice President of International Academy on the Science and Impact of Cannabis

Kenneth Finn, MD has been practicing pain medicine in Colorado Springs since 1994. He is board certified in physical medicine and rehabilitation (1995), pain medicine (1998), and pain management (2000). Finn served on the Colorado Governor’s Task Force on Amendment 64, which legalized marijuana for recreational use, and the Consumer Safety and Social Issues Work Group (2012), as well as served for four years on Colorado’s Medical Marijuana Scientific Advisory Council (2014-18). He has testified to the Canadian Senate on their marijuana bill (2018) and speaks internationally on the health impacts of marijuana, including being invited to the Mayo Clinic in Jacksonville and the Royal College of Surgeons in Ireland. Finn is editor of Cannabis in Medicine: An Evidence-Based Approach, vice president of the International Academy on the Science and Impacts of Cannabis, and president of the American Board of Pain Medicine.


 

 The event is free for TPS Members.

Please log in to your TPS account to register.

Non-TPS Members -- $50 Registration

Register Here

Must be present to receive CME, logged in no later than 15 minutes after the start, and stay through the entirety. 

CME

The Texas Pain Society is accredited by the Texas Medical Association to provide continuing medical education for physicians.

The Texas Pain Society designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only credit commensurate with their participation in this activity.

This course has been designated by the Texas Pain Society for 1.0 credits of education in medical ethics and/or professional responsibility.
This activity contributes to the CME component of The American Board of Anesthesiology® Maintenance of Certification in Anesthesiology® (MOCA®) program, known as MOCA 2.0®. Please consult the ABA website, www.theABA.org, for a list of all MOCA 2.0® requirements. Maintenance of Certification in Anesthesiology® and MOCA® are registered certification marks of the American Board of Anesthesiology®. MOCA 2.0® is a trademark of the American Board of Anesthesiology®.

OBJECTIVES

• Learn about the pharmacology of cannabis.
• Hear about current use cases for it’s medicinal use.
• Learn what impact medical marijuana has on public health.


Target Audience

Texas physicians, advanced practice nurses, nurse practitioners and physician assistants & Texas Legislators


Disclosures to the Learner:

1. Notice of requirements for successful completion of continuing education activity:

  • Register for the course
  • Attend the live presentation in its entirety- Must be logged on with name visible no later than 15 minutes after the start of the program and must remain in the course to its entirety. 
  • Complete the Evaluation

2. The Texas Pain Society's live course has received no commercial support. 

3. Disclosure of financial relationships:

Dr. Kenneth Finn receives royalties for Cannabis in Medicine: An Evidence-Based Approach.

All of the relevant financial relationships listed for these individuals have been mitigated.
All other planners, faculty, committee, board, and moderators for this educational activity have NO relevant financial relationship(s) to disclose with ineligible companies whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.

4. Non-endorsement Statement:

Accredited status does not imply endorsement of any commercial products or services by the Texas Pain Society or the Texas Medical Association.

5. Off-Label Use:

There is no discussion of off-label use in this presentation.